Exploration of immunological responses underpinning severe fever with thrombocytopenia syndrome virus infection reveals IL-6 as a therapeutic target in an immunocompromised mouse model.
Exploration of immunological responses underpinning severe fever with thrombocytopenia syndrome virus infection reveals IL-6 as a therapeutic target in an immunocompromised mouse model.
复制标题
DOI:
10.1093/pnasnexus/pgac024
复制
发表时间:
2022-03
期刊:
影响因子:
--
通讯作者:
Brennan, Benjamin
中科院分区:
文献类型:
--
作者:
Bryden, Steven R.;Dunlop, James I.;Clarke, Andrew T.;Fares, Mazigh;Pingen, Marieke;Wu, Yan;Willett, Brian J.;Patel, Arvind H.;Gao, George F.;Kohl, Alain;Brennan, Benjamin
Dabie bandavirus (previously severe fever with thrombocytopenia syndrome virus; SFTSV), is an emerging tick-borne bunyavirus responsible for severe fever with thrombocytopenia syndrome (SFTS), a disease with high case fatality that is characterized by high fever, thrombocytopenia, and potentially lethal hemorrhagic manifestations. Currently, neither effective therapeutic strategies nor approved vaccines exist for SFTS. Therefore, there remains a pressing need to better understand the pathogenesis of the disease and to identify therapeutic strategies to ameliorate SFTS outcomes. Using a type I interferon (IFN)-deficient mouse model, we investigated the viral tropism, disease kinetics, and the role of the virulence factor nonstructural protein (NSs) in SFTS. Ly6C+ MHCII+ cells in the lymphatic tissues were identified as an important target cell for SFTSV. Advanced SFTS was characterized by significant migration of inflammatory leukocytes, notably neutrophils, into the lymph node and spleen, however, these cells were not required to orchestrate the disease phenotype. The development of SFTS was associated with significant upregulation of proinflammatory cytokines, including high levels of IFN-γ and IL-6 in the serum, lymph node, and spleen. Humoral immunity generated by inoculation with delNSs SFTSV was 100% protective. Importantly, NSs was critical to the inhibition of the host IFNɣ response or downstream IFN-stimulated gene production and allowed for the establishment of severe disease. Finally, therapeutic but not prophylactic use of anti-IL-6 antibodies significantly increased the survival of mice following SFTSV infection and, therefore, this treatment modality presents a novel therapeutic strategy for treating severe SFTS.
登录
查看更多内容
DOI:
10.1016/j.jcv.2018.01.017
发表时间:
2018-04
期刊:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
影响因子:
--
作者:
Kwon JS;Kim MC;Kim JY;Jeon NY;Ryu BH;Hong J;Kim MJ;Chong YP;Lee SO;Choi SH;Kim YS;Woo JH;Kim SH
通讯作者:
Kim SH
影响因子:
6
作者:
Muralidharan A;Reid SP
通讯作者:
Reid SP
影响因子:
5.2
作者:
Matsuno K;Orba Y;Maede-White K;Scott D;Feldmann F;Liang M;Ebihara H
通讯作者:
Ebihara H
影响因子:
8.1
作者:
Hojyo S;Uchida M;Tanaka K;Hasebe R;Tanaka Y;Murakami M;Hirano T
通讯作者:
Hirano T
DOI:
10.4049/jimmunol.1200385
发表时间:
2012-06-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Griffin GK;Newton G;Tarrio ML;Bu DX;Maganto-Garcia E;Azcutia V;Alcaide P;Grabie N;Luscinskas FW;Croce KJ;Lichtman AH
通讯作者:
Lichtman AH